Article
SEC And FDA Sign Memorandum Of Understanding To Share Non-Public Information On FDA-Regulated Public Companies
The SEC and FDA have formalized an information-sharing agreement that fundamentally changes how life sciences companies must approach their public disclosures about FDA interactions. This memorandum of understanding creates a direct pathway for the SEC to access previously confidential FDA records, including meeting minutes and Complete Response Letters, to verify the accuracy of companies' public statements.
WilmerHale